As AMR emerges, new strategies for the treatment of infection and identification of resistant microbes are crucial. This JPIAMR activity, led by the UK Medical Research Council (MRC) with support from South Africa (SAMRC), Korea (NRF), France (ANR), and Canada (CIHR) is delivered as part of JPIAMR’s mission to enable global coordination of research.
The workshop “Feeding the AMR Therapeutics Pipeline” will bring together academics, industry, innovators, and policymakers to discuss the global antimicrobial development pipeline, identify gaps and opportunities for future research and development, and support collaboration for creative solutions to real-world problems facing therapeutics development in the context of antimicrobial resistance (AMR).
The workshop is organised online in three half-day sessions, (13:00-17:00 CET) from the 20th to the 22nd of April 2021, combining keynote presentations, short invited talks selected from abstract submissions, and panel discussions. One of the panel discussions will involve Graham Somers, IMI Portfolio Director, GSK, who will talk about the AMR Accelerator and its goals, among other things.